Table 2.
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Age | 1.08 | 1.04–1.13 | <0.0001 | 1.02 | 0.97–1.08 | 0.343 |
PSA | 1.09 | 1.05–1.14 | <0.0001 | 0.93 | 0.90–1.00 | 0.048 |
PV | 0.97 | 0.95–0.98 | <0.0001 | |||
PSAD 0.1 increase | 1.87 | 1.53–2.36 | <0.0001 | 2.08 | 1.60–2.76 | <0.0001 |
TT | 1.12 | 0.92–1.38 | 0.274 | |||
FT | 0.84 | 0.76–0.92 | 0.0001 | 0.99 | 0.86–1.14 | 0.917 |
%FT 0.01 increase | 0.92 | 0.89–0.96 | <0.0001 | 0.93 | 0.89–0.98 | 0.0042 |
When treating PSAD and %FT as continuous predictors, the odds ratio have been computed for a 0.1 increase in PSAD levels and a 0.01% increase in %FT levels. P value was calculated by likelihood ratio test.
CI, confidence interval; FT, free testosterone; %FT, percent free testosterone; OR, odds ratio; PSA, prostate-specific antigen; PSAD, PSA density; PV, prostate volume; TT, total testosterone.